gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with gadoxetic acid disodium in 5 studies
| Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Studies (gadoxetic acid disodium) | Trials (gadoxetic acid disodium) | Recent Studies (post-2010) (gadoxetic acid disodium) |
|---|---|---|---|---|---|
| 638 | 31 | 243 | 1,720 | 95 | 1,432 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dijkstra, H; Kappert, P; Oudkerk, M; Sijens, PE | 1 |
| Caravan, P; Erstad, DJ; Fuchs, BC; Gale, EM; Jordan, VC; Ramsay, IA; Sojoodi, M; Tanabe, KK | 1 |
| Damm, R; Fischbach, F; Fischbach, K; Gazis, A; Haneder, S; Pech, M; Persigehl, T; Siedek, F; Steinhauser, S; Wenzel, O; Wybranski, C | 1 |
| Froehlich, JM; Guirguis, N; Gutzeit, A; Koh, DM; Kolokythas, O; Matoori, S; Moussa, L; Sartoretti-Schefer, S; Wu, D | 1 |
| Dai, L; Ding, Y; Gao, R; Lan, R; Li, H; Lu, Y; Shu, K; Xu, J; Xu, W; Yan, Z; Ye, F; Ye, X | 1 |
5 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and gadoxetic acid disodium
| Article | Year |
|---|---|
Assessment of the link between quantitative biexponential diffusion-weighted imaging and contrast-enhanced MRI in the liver.
Topics: Adolescent; Adult; Aged; Child; Contrast Media; Diffusion Magnetic Resonance Imaging; Evaluation Studies as Topic; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2017 |
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
Topics: Animals; Breast Neoplasms; Contrast Media; Diamines; Disease Models, Animal; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Manganese Compounds; Mice; Mice, Inbred BALB C; Organometallic Compounds; Picolinic Acids; Tissue Distribution | 2019 |
Respiratory motion artefacts in Gd-EOB-DTPA (Primovist/Eovist) and Gd-DOTA (Dotarem)-enhanced dynamic phase liver MRI after intensified and standard pre-scan patient preparation: A bi-institutional analysis.
Topics: Aged; Artifacts; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Organometallic Compounds; Respiration | 2020 |
Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study.
Topics: Bile; Cholangiography; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Meglumine | 2023 |
Rational Design of Gd-DOTA-Type Contrast Agents for Hepatobiliary Magnetic Resonance Imaging.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Liver Neoplasms; Magnetic Resonance Imaging; Mice | 2023 |